Studies have shown that TSPY is highly expressed in most of the testicular germ cell tumours evaluated and various somatic cancers, including hepatocellular carcinoma, melanoma and prostate cancer, leading to significantly higher morbidity and mortality in men than in women (Kido and Lau, 2019). Here, TSPY1 is linked to prostate cancer.